Adverum Biotechnologies
ADVM
ADVM
100 hedge funds and large institutions have $192M invested in Adverum Biotechnologies in 2018 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.32% more ownership
Funds ownership: 5.57% → 5.89% (+0.32%)
4% less capital invested
Capital invested by funds: $201M → $192M (-$8.83M)
Holders
100
Holding in Top 10
–
Calls
$3.19M
Puts
$187K
Top Buyers
| 1 | +$13.9M | |
| 2 | +$4.38M | |
| 3 | +$3.58M | |
| 4 |
JP Morgan Chase
New York
|
+$2.94M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.65M |
Top Sellers
| 1 | -$8.02M | |
| 2 | -$3.68M | |
| 3 | -$3.1M | |
| 4 |
NC
Nexthera Capital
New York
|
-$2.91M |
| 5 |
DM
Deerfield Management
New York
|
-$2.45M |